New head for CSIRO

Wednesday, 03 September, 2008

Dr Megan Clark has been announced as the new chief executive of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) by Senator Kim Carr, Minister for Innovation, Industry, Science and Research.

Dr Clark will succeed Dr Geoff Garrett, whose term as chief executive ends on 31 December 2008.

Welcoming Dr Clark's appointment, Senator Carr said her experience in science, research and business would allow her to represent the CSIRO on the national and international stage.

"The government is very pleased that Dr Clark has agreed to lead CSIRO," Senator Carr said.

"Her vast leadership experience in the development and application of science and technology in a business environment will be an invaluable asset for CSIRO and for the nation.

"Dr Clark understands the work of CSIRO and appreciates the unique challenges the organisation faces.

"Her experience will also be critical to the central role CSIRO will play in helping to revitalise Australia's national innovation system," he said.

Dr Clark is currently the vice-president health, safety, environment, community and sustainability at BHP Billiton. She has been appointed as chief executive of CSIRO for a five-year term commencing in January 2009.

"I look forward to working with Dr Clark to ensure that CSIRO maintains and strengthens its position as Australia's pre-eminent research organisation," Senator Carr said.

"CSIRO is an important institution for all Australians. I have no doubt that Dr Clark will lead the organisation with vision and purpose."

 

Related News

QIMR Berghofer signs strategic partnership with Nakanoshima Qross

QIMR Berghofer and Japanese biomedical innovation hub Nakanoshima Qross have signed a strategic...

Dr Chris Baldwin is new HaemaLogiX CEO and Managing Director

Having commenced in January, Dr Chris Baldwin is clinical stage Australian biotechnology company...

Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO

To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP)...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd